Logo image of NK.PA

IMERYS SA (NK.PA) Stock Fundamental Analysis

Europe - EPA:NK - FR0000120859 - Common Stock

22.62 EUR
+0.02 (+0.09%)
Last: 9/16/2025, 5:29:30 PM
Fundamental Rating

3

Overall NK gets a fundamental rating of 3 out of 10. We evaluated NK against 13 industry peers in the Construction Materials industry. Both the profitability and financial health of NK have multiple concerns. NK is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

NK had negative earnings in the past year.
In the past year NK had a positive cash flow from operations.
NK had positive earnings in 4 of the past 5 years.
Each year in the past 5 years NK had a positive operating cash flow.
NK.PA Yearly Net Income VS EBIT VS OCF VS FCFNK.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

1.2 Ratios

The Return On Assets of NK (-2.61%) is worse than 76.92% of its industry peers.
Looking at the Return On Equity, with a value of -5.38%, NK is doing worse than 76.92% of the companies in the same industry.
NK's Return On Invested Capital of 3.18% is on the low side compared to the rest of the industry. NK is outperformed by 76.92% of its industry peers.
The Average Return On Invested Capital over the past 3 years for NK is below the industry average of 8.11%.
Industry RankSector Rank
ROA -2.61%
ROE -5.38%
ROIC 3.18%
ROA(3y)0.77%
ROA(5y)1.2%
ROE(3y)1.95%
ROE(5y)2.88%
ROIC(3y)4.04%
ROIC(5y)4.11%
NK.PA Yearly ROA, ROE, ROICNK.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

1.3 Margins

NK's Operating Margin of 6.91% is on the low side compared to the rest of the industry. NK is outperformed by 76.92% of its industry peers.
NK's Operating Margin has declined in the last couple of years.
NK has a better Gross Margin (67.11%) than 92.31% of its industry peers.
In the last couple of years the Gross Margin of NK has grown nicely.
Industry RankSector Rank
OM 6.91%
PM (TTM) N/A
GM 67.11%
OM growth 3Y-6.92%
OM growth 5Y-1.85%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.13%
GM growth 5Y2.94%
NK.PA Yearly Profit, Operating, Gross MarginsNK.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), NK is destroying value.
Compared to 1 year ago, NK has about the same amount of shares outstanding.
Compared to 5 years ago, NK has more shares outstanding
NK has a better debt/assets ratio than last year.
NK.PA Yearly Shares OutstandingNK.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
NK.PA Yearly Total Debt VS Total AssetsNK.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

Based on the Altman-Z score of 1.76, we must say that NK is in the distress zone and has some risk of bankruptcy.
NK has a worse Altman-Z score (1.76) than 69.23% of its industry peers.
The Debt to FCF ratio of NK is 13.35, which is on the high side as it means it would take NK, 13.35 years of fcf income to pay off all of its debts.
NK has a Debt to FCF ratio of 13.35. This is in the lower half of the industry: NK underperforms 76.92% of its industry peers.
NK has a Debt/Equity ratio of 0.59. This is a neutral value indicating NK is somewhat dependend on debt financing.
NK's Debt to Equity ratio of 0.59 is on the low side compared to the rest of the industry. NK is outperformed by 76.92% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.59
Debt/FCF 13.35
Altman-Z 1.76
ROIC/WACC0.56
WACC5.7%
NK.PA Yearly LT Debt VS Equity VS FCFNK.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

NK has a Current Ratio of 2.05. This indicates that NK is financially healthy and has no problem in meeting its short term obligations.
NK has a Current ratio of 2.05. This is in the better half of the industry: NK outperforms 76.92% of its industry peers.
NK has a Quick Ratio of 1.25. This is a normal value and indicates that NK is financially healthy and should not expect problems in meeting its short term obligations.
NK has a Quick ratio of 1.25. This is in the better half of the industry: NK outperforms 61.54% of its industry peers.
Industry RankSector Rank
Current Ratio 2.05
Quick Ratio 1.25
NK.PA Yearly Current Assets VS Current LiabilitesNK.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

1

3. Growth

3.1 Past

NK shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -462.11%.
NK shows a decrease in Revenue. In the last year, the revenue decreased by -7.71%.
Measured over the past years, NK shows a decrease in Revenue. The Revenue has been decreasing by -3.71% on average per year.
EPS 1Y (TTM)-462.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-50.31%
Revenue 1Y (TTM)-7.71%
Revenue growth 3Y-0.55%
Revenue growth 5Y-3.71%
Sales Q2Q%-8.44%

3.2 Future

NK is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -2.30% yearly.
The Revenue is expected to grow by 4.90% on average over the next years.
EPS Next Y-34.48%
EPS Next 2Y-12.85%
EPS Next 3Y-2.3%
EPS Next 5YN/A
Revenue Next Year-5.07%
Revenue Next 2Y-0.81%
Revenue Next 3Y1.01%
Revenue Next 5Y4.9%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
NK.PA Yearly Revenue VS EstimatesNK.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 1B 2B 3B 4B 5B
NK.PA Yearly EPS VS EstimatesNK.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for NK. In the last year negative earnings were reported.
With a Price/Forward Earnings ratio of 9.94, the valuation of NK can be described as very reasonable.
NK's Price/Forward Earnings ratio is rather cheap when compared to the industry. NK is cheaper than 84.62% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of NK to the average of the S&P500 Index (22.77), we can say NK is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 9.94
NK.PA Price Earnings VS Forward Price EarningsNK.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20

4.2 Price Multiples

61.54% of the companies in the same industry are more expensive than NK, based on the Enterprise Value to EBITDA ratio.
NK's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 13.57
EV/EBITDA 6.19
NK.PA Per share dataNK.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

NK's earnings are expected to decrease with -2.30% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-12.85%
EPS Next 3Y-2.3%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 6.69%, NK is a good candidate for dividend investing.
NK's Dividend Yield is rather good when compared to the industry average which is at 3.57. NK pays more dividend than 92.31% of the companies in the same industry.
NK's Dividend Yield is rather good when compared to the S&P500 average which is at 2.38.
Industry RankSector Rank
Dividend Yield 6.69%

5.2 History

The dividend of NK decreases each year by -8.90%.
Dividend Growth(5Y)-8.9%
Div Incr Years1
Div Non Decr Years1
NK.PA Yearly Dividends per shareNK.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2

5.3 Sustainability

The earnings of NK are negative and hence is the payout ratio. NK will probably not be able to sustain this dividend level.
The Dividend Rate of NK has been decling, while earnings will also be declining. This means the current dividend is most likely not sustainable.
DP-74.19%
EPS Next 2Y-12.85%
EPS Next 3Y-2.3%
NK.PA Yearly Income VS Free CF VS DividendNK.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

IMERYS SA

EPA:NK (9/16/2025, 5:29:30 PM)

22.62

+0.02 (+0.09%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryConstruction Materials
Earnings (Last)07-29 2025-07-29
Earnings (Next)10-30 2025-10-30
Inst Owners68.15%
Inst Owner ChangeN/A
Ins Owners0.01%
Ins Owner ChangeN/A
Market Cap1.92B
Analysts80
Price Target29.07 (28.51%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 6.69%
Yearly Dividend1.37
Dividend Growth(5Y)-8.9%
DP-74.19%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-7.07%
PT rev (3m)-25%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-31.27%
EPS NY rev (3m)-31.27%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-2.8%
Revenue NY rev (3m)-4.56%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 9.94
P/S 0.56
P/FCF 13.57
P/OCF 4
P/B 0.62
P/tB 2.18
EV/EBITDA 6.19
EPS(TTM)-1.98
EYN/A
EPS(NY)2.28
Fwd EY10.06%
FCF(TTM)1.67
FCFY7.37%
OCF(TTM)5.66
OCFY25.02%
SpS40.53
BVpS36.4
TBVpS10.37
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.61%
ROE -5.38%
ROCE 4.34%
ROIC 3.18%
ROICexc 3.48%
ROICexgc 6.23%
OM 6.91%
PM (TTM) N/A
GM 67.11%
FCFM 4.11%
ROA(3y)0.77%
ROA(5y)1.2%
ROE(3y)1.95%
ROE(5y)2.88%
ROIC(3y)4.04%
ROIC(5y)4.11%
ROICexc(3y)4.71%
ROICexc(5y)4.71%
ROICexgc(3y)8.34%
ROICexgc(5y)8.54%
ROCE(3y)5.51%
ROCE(5y)5.6%
ROICexcg growth 3Y-6.21%
ROICexcg growth 5Y-5.27%
ROICexc growth 3Y-5.53%
ROICexc growth 5Y-4.67%
OM growth 3Y-6.92%
OM growth 5Y-1.85%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.13%
GM growth 5Y2.94%
F-Score6
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 0.59
Debt/FCF 13.35
Debt/EBITDA 3.4
Cap/Depr 114.1%
Cap/Sales 9.85%
Interest Coverage 3.33
Cash Conversion 89.85%
Profit Quality N/A
Current Ratio 2.05
Quick Ratio 1.25
Altman-Z 1.76
F-Score6
WACC5.7%
ROIC/WACC0.56
Cap/Depr(3y)131.01%
Cap/Depr(5y)116.34%
Cap/Sales(3y)10.27%
Cap/Sales(5y)9.52%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-462.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-50.31%
EPS Next Y-34.48%
EPS Next 2Y-12.85%
EPS Next 3Y-2.3%
EPS Next 5YN/A
Revenue 1Y (TTM)-7.71%
Revenue growth 3Y-0.55%
Revenue growth 5Y-3.71%
Sales Q2Q%-8.44%
Revenue Next Year-5.07%
Revenue Next 2Y-0.81%
Revenue Next 3Y1.01%
Revenue Next 5Y4.9%
EBIT growth 1Y-15.73%
EBIT growth 3Y-7.43%
EBIT growth 5Y-5.49%
EBIT Next Year116.15%
EBIT Next 3Y32.76%
EBIT Next 5YN/A
FCF growth 1Y96.12%
FCF growth 3Y-17.98%
FCF growth 5Y-13.24%
OCF growth 1Y-0.33%
OCF growth 3Y-4.3%
OCF growth 5Y-1.59%